Lower risks of heart disease, stroke, certain cancers, and diabetes complications provide peace of mind and potential healthcare cost savings over time
C., Werner, S., Barrandon, Y., & Longaker, M
Dulaglutide (Trulicity): A Weekly GLP-1 Agonist for Long-Term Glycemic Control Dulaglutide is another GLP-1 manufactured by the pharmaceutical company Eli-Lilly with the brand name Trulicity
Evidence regarding specific clinical outcomes from subcutaneous lipotropic injections is still evolving (Rajman et al., 2018)
10.1111/dom.12963 Summary Keywords schizophrenia, systematic review, meta-analysis, GLP-1 receptor agonists, treatment Citation Khaity A, Mostafa Al-dardery N, Albakri K, Abdelwahab OA, Hefnawy MT, Yousef YAS, Taha RE, Swed S, Hafez W, Hurlemann R and Elsayed MEG (2023) Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in schizophrenia patients: a systematic review and meta-analysis